Cepravin Dry Cow 250 mg Intramammary Suspension

Страна: Велика Британія

мова: англійська

Джерело: VMD (Veterinary Medicines Directorate)

Активний інгредієнт:

Cephalonium

Доступна з:

MSD Animal Health UK Limited

Код атс:

QJ51DB90

ІПН (Міжнародна Ім'я):

Cephalonium

Фармацевтична форма:

Intramammary suspension

Тип рецепту:

POM-V - Prescription Only Medicine – Veterinarian

Терапевтична група:

Cattle

Терапевтична области:

Antimicrobial intramammary

Статус Авторизація:

Authorized

Дата Авторизація:

1993-01-01

Характеристики продукта

Revised: March 2021
AN: 01885/2020
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cepravin Dry Cow 250mg Intramammary suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Constituent:
per syringe
Cefalonium
0.250 g
(as cefalonium dihydrate)
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Intramammary suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Recommended
for
routine
dry
cow
therapy
to
treat
existing
sub-clinical
infections and to prevent new infections which occur during the dry
period.
4.3
CONTRAINDICATIONS
Not for use in the lactating cow.
Not intended for use within 54 days of calving.
4.4
SPECIAL WARNINGS:
No special warnings are considered necessary.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Use of the product should be based on susceptibility testing of the
bacteria
isolated from milk samples from the animal. If this is not possible,
therapy
should be based on local (regional, farm level) epidemiological
information
about susceptibility of the target bacteria.
Revised: March 2021
AN: 01885/2020
Page 2 of 8
Use of the product deviating from the instructions given in the SPC
may
increase
the
prevalence
of
bacteria
resistant
to
cefalonium
and
may
decrease the effectiveness of treatment with other beta lactams.
Dry
cow
therapy
protocols
should
take
local
and
national
policies
on
antimicrobial use into consideration, and undergo regular veterinary
review.
The feeding to calves of milk containing residues of cefalonium that
could
select for antimicrobial-resistant bacteria (e.g. production of
beta-lactamases)
should be avoided up to the end of the milk withdrawal period, except
during
the colostral phase.
The efficacy of the product has only been established against
pathogens
sensitive
to
the
active
substance.
Consequently,
serious
acute
mastitis
(potentially fatal) due to other pathogen species, particularly _
Pseudomonas _
_aeruginosa